Access the full text.
Sign up today, get DeepDyve free for 14 days.
Angus Mcquibban, G. Butler, J. Gong, L. Bendall, C. Power, I. Clark‐Lewis, Christopher Overall (2001)
Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1*The Journal of Biological Chemistry, 276
ICH Harmonised Tripartite Guideline International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (2005)
Text and Methodology Q2
Yuhui Wang, Peilian Shen, Chunya Li, Yanying Wang, Zhihong Liu (2012)
Upconversion fluorescence resonance energy transfer based biosensor for ultrasensitive detection of matrix metalloproteinase-2 in blood.Analytical chemistry, 84 3
Annette Wysocki, Lisa Staiano-Coico, Frederick Grinnell (1993)
Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9.The Journal of investigative dermatology, 101 1
S. Eissa, R. Ali-Labib, M. Swellam, M. Bassiony, F. Tash, T. El-Zayat (2007)
Noninvasive diagnosis of bladder cancer by detection of matrix metalloproteinases (MMP-2 and MMP-9) and their inhibitor (TIMP-2) in urine.European urology, 52 5
N. Laraki, N. Franceschini, G. Rossolini, P. Santucci, C. Meunier, E. Pauw, G. Amicosante, J. Frère, M. Galleni (1999)
Biochemical Characterization of the Pseudomonas aeruginosa 101/1477 Metallo-β-Lactamase IMP-1 Produced byEscherichia coliAntimicrobial Agents and Chemotherapy, 43
M. Moses, D. Wiederschain, K. Loughlin, D. Zurakowski, C. Lamb, M. Freeman (1998)
Increased incidence of matrix metalloproteinases in urine of cancer patients.Cancer research, 58 7
R. Roy, D. Zurakowski, J. Wischhusen, Christine Frauenhoffer, Susanne Hooshmand, M. Kulke, M. Moses (2014)
Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignanciesBritish Journal of Cancer, 111
S. Aaronson (1991)
Growth factors and cancer.Science, 254 5035
R. Roy, Jiang Yang, M. Moses (2009)
Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27 31
Yong Han, Hyeong Chun, H. Yoon (2014)
The transformation of common office supplies into a low-cost optical biosensing platform.Biosensors & bioelectronics, 59
P. Fitzsimmons, R. Forough, M. Lawrence, D. Gantt, M. Rajab, Hyun-Sock Kim, B. Weylie, A. Spiekerman, G. Dehmer (2007)
Urinary levels of matrix metalloproteinase 9 and 2 and tissue inhibitor of matrix metalloproteinase in patients with coronary artery disease.Atherosclerosis, 194 1
Jie Yang, Zhihong Zhang, Juqiang Lin, Jinling Lu, Bifeng Liu, S. Zeng, Qingming Luo (2007)
Detection of MMP activity in living cells by a genetically encoded surface-displayed FRET sensor.Biochimica et biophysica acta, 1773 3
C. Bebrone, C. Moali, F. Mahy, S. Rival, J. Docquier, G. Rossolini, J. Fastrez, R. Pratt, J. Frère, M. Galleni (2001)
CENTA as a Chromogenic Substrate for Studying β-LactamasesAntimicrobial Agents and Chemotherapy, 45
M. Duffy (1992)
The role of proteolytic enzymes in cancer invasion and metastasisClinical & Experimental Metastasis, 10
A. Carlo, A. Mariano, D. Terracciano, M. Ferro, V. Montanaro, M. Marsicano, G. Lorenzo, V. Altieri, V. Macchia (2010)
Matrix metalloproteinase-2 and -9 in the urine of prostate cancer patients.Oncology reports, 24 1
J. Westermarck, V. Kähäri (1999)
Regulation of matrix metalloproteinase expression in tumor invasionThe FASEB Journal, 13
(1976)
SantucCopyright for the published papers belongs to the Korean BioChip Society
C. Kleber, A. Spiess, J. Kleber, U. Hinz, Stefan Holland-Cunz, J. Weiss (2012)
Urinary matrix metalloproteinases-2/9 in healthy infants and haemangioma patients prior to and during propranolol therapyEuropean Journal of Pediatrics, 171
D. Angelo (2006)
Metabolic Emergencies in Oncology
Christine Coticchia, A. Curatolo, D. Zurakowski, Jiang Yang, Kathryn Daniels, U. Matulonis, M. Moses (2011)
Urinary MMP-2 and MMP-9 predict the presence of ovarian cancer in women with normal CA125 levels.Gynecologic oncology, 123 2
S. Zucker, J. Vacirca (2004)
Role of matrix metalloproteinases (MMPs) in colorectal cancerCancer and Metastasis Reviews, 23
N. Franceschini N. Laraki (1999)
Biochemical Characterization of the Pseudomonas aeruginosa 101/1477 Metallo-Lactamase IMP-1 Produced by Escherichia coli. Antimicrob. AgentsChemother., 43
E. Smith, D. Zurakowski, A. Saad, R. Scott, M. Moses (2008)
Urinary Biomarkers Predict Brain Tumor Presence and Response to TherapyClinical Cancer Research, 14
S. Rosenberg (1999)
A new era for cancer immunotherapy based on the genes that encode cancer antigens.Immunity, 10 3
A. Carlo, D. Terracciano, A. Mariano, V. Macchia (2006)
Urinary gelatinase activities (matrix metalloproteinases 2 and 9) in human bladder tumors.Oncology reports, 15 5
Hajin Kim, H. Yoon, T. Yoo (2014)
Engineering β-lactamase zymogens for use in protease activity assays.Chemical communications, 50 70
T. Turpeenniemi‐Hujanen (2005)
Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers.Biochimie, 87 3-4
Ci-mei Wang, Chun-Lan Zhan, Qiu-Feng Cai, Cuihong Du, Guangming Liu, W. Su, M. Cao (2014)
Expression and characterization of common carp (Cyprinus carpio) matrix metalloproteinase-2 and its activity against type I collagen.Journal of biotechnology, 177
Abstract Matrix metalloproteinase-2 (MMP-2) is closely related to the proliferation and invasion of various types of cancers. The protease is secreted by malignant tumor cells, thus allowing the enzyme to serve as a biomarker for cancer diagnosis. Methods have been developed to analyze MMP-2 activities; however, their applications to disease diagnosis have not been widely demonstrated yet because of the need for highend analytical equipment and labor-intensive processes. In this study, we developed an MMP-2 activity assay system by integrating an engineered autoinhibited β-lactamase which can be activated by MMP-2 in an optical sensing system consisting of reassembled common electronic components, such as a laser diode, a solar cell, and a multimeter. The autoinhibited β-lactamase was immobilized on a polymeric biosensing channel by a polydopamine coating and self-assembled monolayer methods. In the presence of MMP-2, the immobilized autoinhibited β-lactamase was converted to an active form that hydrolyzed the chromogenic cephalosporin CENTA, thereby changing the substrate color from pale yellow (λmax=340 nm) to highly discernible chrome yellow (λmax=405 nm). By reading the interfered laser-light intensity, we were able to analyze MMP-2 activities precisely both with the samples prepared in a buffer solution and also those in urine. These results suggested that the developed system can be used for the quantitative analysis of enzyme activity related to cancer diagnosis.
BioChip Journal – Springer Journals
Published: Sep 1, 2016
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.